SELLAS Life Sciences Group, Inc. SLS Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Returns | |||||
| Return on equity | -66.9%— | —— | —— | -327.8%-242pp | |
| Return on assets | -54.9%+186pp | -240.8%+34.2pp | -274.9%-100pp | -174.9%-118pp | |
| Liquidity | |||||
| Current ratio | 10.7×+9.0× | 1.7×+1.5× | 0.2×-0.9× | 1.1×-3.5× | |
| Quick ratio | 10.7×+9.0× | 1.7×+1.5× | 0.2×-0.9× | 1.1×-3.5× | |
| Cash ratio | 10.2×+8.8× | 1.5×+1.3× | 0.2×-0.9× | 1.1×-3.2× | |
| Leverage | |||||
| Debt-to-equity | 0×-0.1× | 0.1×— | —— | 0.2×+0.2× | |
| Debt-to-assets | 0×0.0× | 0.1×-0.1× | 0.1×+0.1× | 0×0.0× | |
| Interest coverage | -20×+29.8× | -49.9×+22.3× | -72.1×— | —— | |
| Per Share | |||||
| Book value per share | $0.65+320% | $0.15+154% | -$0.29-215% | $0.25-81.0% | |
| Valuation | |||||
| Market capitalization | $537.01M+634% | $73.2M+115% | $33.99M-30.1% | $48.59M-44.7% | |
| Enterprise value | $466.22M+673% | $60.31M+86.4% | $32.36M-0.1% | $32.41M-51.8% | |
| Price / book | 7.6×-0.2× | 7.7×— | —— | 10×+5.7× | |
| Earnings yield | -5%+37.2pp | -42.2%+67.7pp | -109.9%-24.9pp | -85%-61.4pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are SELLAS Life Sciences Group, Inc.'s profit margins?
- SELLAS Life Sciences Group, Inc. (SLS) runs a 90.0% gross margin and a -4195.0% operating margin, with a -4130.1% net margin.
- Where do SELLAS Life Sciences Group, Inc.'s ratios come from?
- Every ratio is computed from SELLAS Life Sciences Group, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.